Indication

Chronic indeterminate Chagas disease

Chronic indeterminate Chagas disease is the latent, subclinical stage of persistent infection caused by the protozoan parasite *Trypanosoma cruzi*. Read more about Chronic indeterminate Chagas disease

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Chronic indeterminate Chagas disease therapies.

Showing 1–1 of 1 drugs

BENZNIDAZOLE

ANTIPROTOZOAL AGENTS·CHRONIC INDETERMINATE CHAGAS DISEASE
Everett Laboratories
Filter & compare in the drug finder →Opens the drug finder with Chronic indeterminate Chagas disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic indeterminate Chagas disease.

Chronic indeterminate Chagas disease is the latent, subclinical stage of persistent infection caused by the protozoan parasite *Trypanosoma cruzi*.

It primarily affects infected pediatric and adult populations without overt clinical illness, representing the majority of chronic cases following the resolution of the acute phase.

Pathophysiologically, low-level intracellular parasite persistence and a host immune equilibrium characterize this state.

Clinically, it is defined by reactive serological testing for *T.

cruzi* antibodies alongside a total absence of clinical symptoms, normal electrocardiographic findings, and no evidence of cardiac, gastrointestinal, or autonomic organ damage.

Personalize your experience

Follow Chronic indeterminate Chagas disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it